ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 130 filers reported holding ARCUS BIOSCIENCES INC in Q3 2020. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $947,112 | +18.6% | 51,925 | +34.4% | 0.13% | -0.8% |
| Q4 2022 | $798,806 | -47.8% | 38,627 | -34.0% | 0.13% | -44.4% |
| Q3 2022 | $1,531,000 | +118.7% | 58,528 | +111.9% | 0.23% | +274.2% |
| Q2 2022 | $700,000 | +243.1% | 27,618 | +446.8% | 0.06% | +287.5% |
| Q4 2021 | $204,000 | -51.0% | 5,051 | -79.2% | 0.02% | -40.7% |
| Q3 2020 | $416,000 | +76.3% | 24,247 | +42.4% | 0.03% | +42.1% |
| Q1 2020 | $236,000 | +19.2% | 17,033 | -12.9% | 0.02% | +58.3% |
| Q4 2019 | $198,000 | -5.7% | 19,562 | -15.3% | 0.01% | 0.0% |
| Q3 2019 | $210,000 | +57.9% | 23,100 | +38.3% | 0.01% | +50.0% |
| Q2 2019 | $133,000 | – | 16,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $40,850,000 | 24.66% |
| Octagon Capital Advisors LP | 2,669,974 | $67,657,000 | 18.06% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $22,040,000 | 8.36% |
| BVF INC/IL | 3,960,948 | $100,370,000 | 4.85% |
| Finepoint Capital LP | 535,000 | $13,557,000 | 4.69% |
| PFM Health Sciences, LP | 3,346,458 | $84,799,000 | 3.24% |
| ACUTA CAPITAL PARTNERS, LLC | 167,500 | $4,244,000 | 2.36% |
| Boxer Capital, LLC | 1,432,200 | $36,292,000 | 2.30% |
| Parkman Healthcare Partners LLC | 171,214 | $4,339,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 311,782 | $7,901,000 | 1.59% |